SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 41 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $9,972,500 | +1.3% | 10,000,000 | 0.0% | 0.05% | +6.5% |
Q4 2022 | $9,841,900 | +0.7% | 10,000,000 | 0.0% | 0.05% | +2.2% |
Q3 2022 | $9,776,000 | +0.8% | 10,000,000 | 0.0% | 0.04% | +7.1% |
Q2 2022 | $9,697,000 | -0.8% | 10,000,000 | 0.0% | 0.04% | +13.5% |
Q1 2022 | $9,771,000 | -1.6% | 10,000,000 | 0.0% | 0.04% | 0.0% |
Q4 2021 | $9,925,000 | +0.6% | 10,000,000 | 0.0% | 0.04% | -14.0% |
Q3 2021 | $9,868,000 | -0.4% | 10,000,000 | 0.0% | 0.04% | -4.4% |
Q2 2021 | $9,910,000 | +2.6% | 10,000,000 | 0.0% | 0.04% | -15.1% |
Q1 2021 | $9,658,000 | +2.2% | 10,000,000 | 0.0% | 0.05% | -3.6% |
Q4 2020 | $9,448,000 | +2.3% | 10,000,000 | 0.0% | 0.06% | -6.8% |
Q3 2020 | $9,237,000 | +4.4% | 10,000,000 | 0.0% | 0.06% | -6.3% |
Q2 2020 | $8,846,000 | +8.8% | 10,000,000 | 0.0% | 0.06% | -1.6% |
Q1 2020 | $8,133,000 | -31.1% | 10,000,000 | -23.1% | 0.06% | +10.3% |
Q4 2019 | $11,809,000 | -43.1% | 13,008,000 | -41.7% | 0.06% | -48.7% |
Q3 2019 | $20,750,000 | -4.9% | 22,303,000 | 0.0% | 0.11% | -6.6% |
Q2 2019 | $21,829,000 | – | 22,303,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|